三七
人参皂甙
糖苷水解酶
产量(工程)
化学
五加科
生物化学
酶
人参
医学
材料科学
病理
冶金
替代医学
作者
Yuaner Sui,Bin Wei,Zichen Wang,Hao Liang
标识
DOI:10.1021/acs.jafc.5c06103
摘要
Ginsenoside F1 (G-F1), a therapeutically valuable compound from Panax notoginseng, faces production challenges due to its low natural abundance. Herein, we engineered the glycoside hydrolase BgDU via structure-based design for efficient bioconversion of Notoginsenoside R1 (NG-R1) to G-F1. Through a semirational design approach, we generated the triple mutant I73L/G138H/W509Y (DUase). This engineered variant demonstrated significant catalytic improvements, showing an 85-fold reduction in KM for NG-R1 along with 16-fold and 5-fold increases in kcat/KM values for NG-R1 and ginsenoside Rg1, respectively. DUase achieved a 95.02% molar yield of G-F1 (12.82 g/L) within 10 h, while reducing the byproduct Rh1 to below 0.7 g/L. DUase's catalytic improvement resulted from a remodeled substrate channel with expanded proximal and contracted distal regions, overcoming the classic activity-selectivity trade-off and enabling scalable production of rare ginsenosides.
科研通智能强力驱动
Strongly Powered by AbleSci AI